Company Overview of CoDa Therapeutics, Inc.
CoDa Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics for wound care, inflammation, and tissue repair based on a gap junction modulation in the United States and Europe. The company offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was incorporated in 2005 and is based in San Diego, California.
10505 Sorrento Valley Road
San Diego, CA 92121
Founded in 2005
Key Executives for CoDa Therapeutics, Inc.
CoDa Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Omniome, Inc.||United States|
|NeoGenex Inc.||United States|
|Durata Therapeutics, Inc.||United States|
|Phage International, Inc.||United States|
|Acureon Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
June 4, 2015
February 5, 2015
To contact CoDa Therapeutics, Inc., please visit www.codatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.